EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Electroporation in Translational Medicine: From Veterinary Experience to Human Oncology

Enrico P Spugnini, Maria Condello iD, Stefania Crispi, Alfonso Baldi iD

Cancers · 06.03.2024 · 16 (5) · 1067

DOI: 10.3390/cancers16051067 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 06.03.2024. Verfasst von Enrico P Spugnini und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biopulse Srl, 00144 Rome, Italy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MUR PRIN PNRR, CNR project FOE-2021, Fondazione Futura onlus.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Electroporation (EP) is a broadly accepted procedure that, through the application of electric pulses with appropriate amplitudes and waveforms, promotes the delivery of anticancer molecules in various oncology therapies. EP considerably boosts the absorptivity of targeted cells to anticancer molecules of different natures, thus upgrading their effectiveness. Its use in veterinary oncology has been widely explored, and some applications, such as electrochemotherapy (ECT), are currently approved as first-line treatments for several neoplastic conditions. Other applications include irreversible electroporation and EP-based cancer vaccines. In human oncology, EP is still mostly restricted to therapies for cutaneous tumors and the palliation of cutaneous and visceral metastases of malignant tumors. Fields where veterinary experience could help smooth the clinical transition to humans include intraoperative EP, interventional medicine and cancer vaccines. This article recapitulates the state of the art of EP in veterinary and human oncology, recounting the most relevant results to date.

Schlagwörter

Stichwörter der Autor:innen

cancer vaccineelectrochemotherapyelectroimmunotherapyirreversible electroporation

Autor:innen und Institutionen

  • Biopulse Srl, 00144 Rome, Italy.
  • Istituto Superiore di Sanità, 00161 Rome, Italy.
  • Institute of Biosciences and BioResources-UOS Naples CNR, Via P. Castellino 111, 80131 Naples, Italy.
  • Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, Campania University "Luigi Vanvitelli", 81100 Caserta, Italy.

ORCID-Profile: Maria Condello, Alfonso Baldi

Förderung

  • MUR PRIN PNRR
  • CNR project FOE-2021
  • Fondazione Futura onlus

Zitieren

APA

Spugnini, E. P., Condello, M., Crispi, S., & Baldi, A. (2024). Electroporation in Translational Medicine: From Veterinary Experience to Human Oncology. Cancers, 16(5), 1067. https://doi.org/10.3390/cancers16051067

Vancouver

Spugnini EP, Condello M, Crispi S, Baldi A. Electroporation in Translational Medicine: From Veterinary Experience to Human Oncology. Cancers. 2024;16(5):1067. doi:10.3390/cancers16051067

BibTeX
@article{Spugnini2024,
  author = {Spugnini, Enrico P and Condello, Maria and Crispi, Stefania and Baldi, Alfonso},
  title = {Electroporation in Translational Medicine: From Veterinary Experience to Human Oncology},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {5},
  pages = {1067},
  doi = {10.3390/cancers16051067}
}
Kostenlos starten →